Session Information

Invited Symposium

[IS-TH-82] Conjunctival Tumors: Innovations in Management
Go back
print
Day
Apr 03 (Thu)
Time
15:30 - 17:00
Room
Room 27 - Imperial Hotel 3F Mai
Topic
Oncology
Chair/Coordinator
Chair)Hiroshi Goto、Chair)Maria Manquez、Chair)Jerry Shields
Description
This session will begin with a general overview of the most important conjunctival tumors. Following this introduction, there will be updates on the 3 most important malignant intraocular tumors, namely melanoma, squamous cell carcinoma and lymphoma. Emphasis will be placed on current surgical management and the use of ancillary modalities like cryotherapy, injections of medications to assist in tumor control, and radiotherapy. Finally there will be a discussion on special techniques in histopathology of conjunctival tumors. After completed this session, the attendee will have a better knowledge of how to recognize a variety of conjunctival tumors and will better understand options in management, basic management techniques, and when to refer patients to subspecialists who deal specifically with such lesions.

Duraion 9min, 1min Q&A, Panel Discussion = Last 30min

IS-TH-82-1 / 

Oncology

Overview of Conjunctival Tumors

Jerry Shields

Overview of Conjunctival Tumors

Duraion 9min, 1min Q&A, Panel Discussion = Last 30min

IS-TH-82-2 / 

Oncology

Local Chemotherapy in Malignant Conjunctival Tumor

Satoru Kase

Local Chemotherapy in Malignant Conjunctival Tumor

Duraion 9min, 1min Q&A, Panel Discussion = Last 30min

IS-TH-82-3 / 

Oncology

Tips in the Management of Conjunctival Melanoma

Bertil Damato

Tips in the Management of Conjunctival Melanoma

Duraion 9min, 1min Q&A, Panel Discussion = Last 30min

IS-TH-82-4 / 

Oncology

Interferon for Squamous Cell Carcinoma

Carol Shields

Interferon for Squamous Cell Carcinoma

Duraion 9min, 1min Q&A, Panel Discussion = Last 30min

IS-TH-82-5 / 

Oncology

Management of Conjunctival Lymphoma

Maria Manquez

Management of Conjunctival Lymphoma

Duraion 9min, 1min Q&A, Panel Discussion = Last 30min

IS-TH-82-6 / 

Oncology

Malignant Conjunctival Tumor That One Should Not Miss

Hiroshi Goto

Malignant Conjunctival Tumor That One Should Not Miss

Go back